About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Epidemiology of NAFLD in Children and Adolescents

NCT05526274·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Carmen Expósito Martínez, PhD
CONTACT
93 741 53 38 cexposito.mn.ics@gencat.cat
Carla Chacón Valera, MS
CONTACT
93 741 53 38 cchaconv.mn.ics@gencat.cat

Lead

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

With

Hospital del Mar Research Institute (IMIM)
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Fundació Institut Germans Trias i Pujol

Age

9–16

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Subjects aged between 9 and 16 years.
Subjects whose parents/legal guardians have signed the informed consent.
For subjects over 12 years: it will also be necessary to have their own signed informed consent.

You may not be if

Subjects with previously diagnosed liver disease.
Subjects receiving hepatotoxic drug treatment.
Subjects with diagnosed eating disorders.

The record

StatusUnknown

PhaseNo phase

Taking part2,866

StartedOct 2022

UpdatedSep 2, 2022

Conditions

Non-Alcoholic Fatty Liver Disease Childhood Obesity

Where1

IDIAP Jordi Gol i Gurina
Mataró, Barcelona, Spain

Clareo Health | Clinical Epidemiology of NAFLD in Children and Adolescents